Search

everythinglearnresearchcommunity

for

Search:↓

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

CXCR2 in skin cells promotes tumor growth.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

CD2 might be a new treatment target for patchy alopecia areata.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

CS12192 effectively treats alopecia areata with better safety than current options.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

CD99 is highly present in certain skin cells and could help treat skin conditions.

Soluble CD83 speeds up wound healing and reduces scarring.

A specific group of skin stem cells was found to help maintain hair follicle cells.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Calancardin B may help reduce inflammation in immune cells.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.